GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Catheter Precision Inc (FRA:4RM) » Definitions » EV-to-EBIT

Catheter Precision (FRA:4RM) EV-to-EBIT : -0.29 (As of Jun. 18, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Catheter Precision EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Catheter Precision's Enterprise Value is €2.52 Mil. Catheter Precision's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was €-8.69 Mil. Therefore, Catheter Precision's EV-to-EBIT for today is -0.29.

The historical rank and industry rank for Catheter Precision's EV-to-EBIT or its related term are showing as below:

FRA:4RM' s EV-to-EBIT Range Over the Past 10 Years
Min: -12.27   Med: 0.16   Max: 0.68
Current: -0.29

During the past 8 years, the highest EV-to-EBIT of Catheter Precision was 0.68. The lowest was -12.27. And the median was 0.16.

FRA:4RM's EV-to-EBIT is ranked worse than
100% of 450 companies
in the Medical Devices & Instruments industry
Industry Median: 19.165 vs FRA:4RM: -0.29

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Catheter Precision's Enterprise Value for the quarter that ended in Mar. 2024 was €2.10 Mil. Catheter Precision's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was €-8.69 Mil. Catheter Precision's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -414.82%.


Catheter Precision EV-to-EBIT Historical Data

The historical data trend for Catheter Precision's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Catheter Precision EV-to-EBIT Chart

Catheter Precision Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial 0.20 -0.13 0.06 0.14 0.02

Catheter Precision Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 0.09 0.10 0.02 -0.26

Competitive Comparison of Catheter Precision's EV-to-EBIT

For the Medical Devices subindustry, Catheter Precision's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Catheter Precision's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Catheter Precision's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Catheter Precision's EV-to-EBIT falls into.



Catheter Precision EV-to-EBIT Calculation

Catheter Precision's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=2.521/-8.694
=-0.29

Catheter Precision's current Enterprise Value is €2.52 Mil.
Catheter Precision's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-8.69 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Catheter Precision  (FRA:4RM) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Catheter Precision's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=-8.694/2.0958418
=-414.82 %

Catheter Precision's Enterprise Value for the quarter that ended in Mar. 2024 was €2.10 Mil.
Catheter Precision's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-8.69 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Catheter Precision EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Catheter Precision's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Catheter Precision (FRA:4RM) Business Description

Traded in Other Exchanges
Address
1670 Highway 160 West, Suite 205, Fort Mill, SC, USA, 29708
Catheter Precision Inc Formerly Ra Medical Systems Inc is a commercial-stage medical device company whose business comprises of the design, manufacture and sale of new medical technologies in the field of cardiac electrophysiology, or EP. Its product, View into Ventricular Onset System or VIVO System which is a non invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. . It operates business as one segment which includes all activities related to the marketing, sales and development of medical technologies in the field of cardiac EP.

Catheter Precision (FRA:4RM) Headlines

No Headlines